UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Variants in the CETP gene affect levels of HDL cholesterol by reducing the amount, and not the specific lipid transfer activity, of secreted CETP

PloS one, 2023-12, Vol.18 (12), p.e0294764-e0294764

2023

Volltextzugriff (PDF)

Flavonoids regulate LDLR through different mechanisms tied to their specific structures

Journal of lipid research, 2024-05, Vol.65 (5), p.100539-100539, Article 100539

2024

Volltextzugriff (PDF)

Functional characterization of missense variants affecting the extracellular domains of ABCA1 using a fluorescence-based assay

Journal of lipid research, 2024-01, Vol.65 (1), p.100482-100482, Article 100482

2024

Volltextzugriff (PDF)

MK-2206, an allosteric inhibitor of AKT, stimulates LDLR expression and LDL uptake: A potential hypocholesterolemic agent

Atherosclerosis, 2018-09, Vol.276, p.28-38

2018

Volltextzugriff (PDF)

PCSK9 acts as a chaperone for the LDL receptor in the endoplasmic reticulum

Biochemical journal, 2014-01, Vol.457 (1), p.99-105

2014

Volltextzugriff (PDF)

Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects

Europace (London, England), 2014-04, Vol.16 (4), p.563-571

2014

Volltextzugriff (PDF)

Missense mutation Q384K in the APOB gene affecting the large lipid transfer module of apoB reduces the secretion of apoB-100 in the liver without reducing the secretion of apoB-48 in the intestine

Journal of clinical lipidology, 2023-11, Vol.17 (6), p.800-807

2023

Volltextzugriff (PDF)

Sorting an LDL receptor with bound PCSK9 to intracellular degradation

Atherosclerosis, 2014-11, Vol.237 (1), p.76-81

Leren, Trond P

2014

Volltextzugriff (PDF)

Effect of mutations in the PCSK9 gene on the cell surface LDL receptors

Human molecular genetics, 2006-05, Vol.15 (9), p.1551-1558

2006

Volltextzugriff (PDF)

The risk of various types of cardiovascular diseases in mutation positive familial hypercholesterolemia; a review

Frontiers in genetics, 2022-12, Vol.13, p.1072108-1072108

2022

Volltextzugriff (PDF)

Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treated

PloS one, 2011-02, Vol.6 (2), p.e16721-e16721

2011

Volltextzugriff (PDF)

PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment

Journal of lipid research, 2013-06, Vol.54 (6), p.1560-1566

2013

Volltextzugriff (PDF)

Role of the C-terminal domain of PCSK9 in degradation of the LDL receptors

Journal of lipid research, 2011-10, Vol.52 (10), p.1787-1794

2011

Volltextzugriff (PDF)

Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993–2020

Atherosclerosis, 2021-04, Vol.322, p.61-66

2021

Volltextzugriff (PDF)

Cascade screening for familial hypercholesterolemia should be organized at a national level

Current opinion in lipidology, 2022-08, Vol.33 (4), p.231-236

2022

Volltextzugriff (PDF)

Mutations in the SORT1 gene are unlikely to cause autosomal dominant hypercholesterolemia

Atherosclerosis, 2012-12, Vol.225 (2), p.370-375

2012

Volltextzugriff (PDF)

Molecular genetics in 4408 cardiomyopathy probands and 3008 relatives in Norway: 17 years of genetic testing in a national laboratory

European journal of preventive cardiology, 2022-10, Vol.29 (13), p.1789-1799

2022

Volltextzugriff (PDF)

Bone morphogenetic protein 1 cleaves the linker region between ligand-binding repeats 4 and 5 of the LDL receptor and makes the LDL receptor non-functional

Human molecular genetics, 2020-05, Vol.29 (8), p.1229-1238

2020

Volltextzugriff (PDF)

Berberine decreases PCSK9 expression in HepG2 cells

Atherosclerosis, 2008-12, Vol.201 (2), p.266-273

2008

Volltextzugriff (PDF)

Retention of Mutant Low Density Lipoprotein Receptor in Endoplasmic Reticulum (ER) Leads to ER Stress

The Journal of biological chemistry, 2006-01, Vol.281 (1), p.468-476

2006

Volltextzugriff (PDF)

Molecular genetics in 1991 arrhythmia probands and 2782 relatives in Norway: Results from 17 years of genetic testing in a national laboratory

Clinical genetics, 2024-11, Vol.106 (5), p.585-602

2024

Volltextzugriff (PDF)

Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia

Heart (British Cardiac Society), 2018-10, Vol.104 (19), p.1600-1607

2018

Volltextzugriff (PDF)

Excess Aortic Pathology Risk in Patients with Genetically Verified Familial Hypercholesterolaemia: A Prospective Norwegian Registry Study

European journal of vascular and endovascular surgery, 2021-04, Vol.61 (4), p.712-713

2021

Volltextzugriff (PDF)

The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: Results from twenty years of a national screening program in Norway

Journal of clinical lipidology, 2021-09, Vol.15 (5), p.674-681

2021

Volltextzugriff (PDF)

1 – 25 von 179

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(166)
Mit Volltextzugriff
(148)

Publikationsform

Artikel
(174)
Berichte
(4)
Reviews
(1)

Sprache

Englisch
(156)
Norwegisch
(20)
Bokmål, Norwegian; Norwegian Bokmål
(10)
Spanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(126)
Life Sciences & Biomedicine
(123)
Humans
(116)
Male
(64)
Female
(59)
Mutation
(59)
Adult
(45)
Biological And Medical Sciences
(40)
Middle Aged
(40)
Cardiovascular System & Cardiology
(38)
Genetics & Heredity
(38)
Familial Hypercholesterolemia
(34)
Medical Sciences
(34)
Hyperlipoproteinemia Type Ii - Genetics
(33)
Receptors, Ldl - Genetics
(32)
Cardiac & Cardiovascular Systems
(31)
Biochemistry & Molecular Biology
(28)
Receptors, Ldl - Metabolism
(26)
Adolescent
(24)
Child
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Variants in the CETP gene affect levels of HDL cholesterol by reducing the amount, and not the specific lipid transfer activity, of secreted CETP

Flavonoids regulate LDLR through different mechanisms tied to their specific structures

Functional characterization of missense variants affecting the extracellular domains of ABCA1 using a fluorescence-based assay

MK-2206, an allosteric inhibitor of AKT, stimulates LDLR expression and LDL uptake: A potential hypocholesterolemic agent

PCSK9 acts as a chaperone for the LDL receptor in the endoplasmic reticulum

Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects

Missense mutation Q384K in the APOB gene affecting the large lipid transfer module of apoB reduces the secretion of apoB-100 in the liver without reducing the secretion of apoB-48 in the intestine

Sorting an LDL receptor with bound PCSK9 to intracellular degradation

Prospective, population-based long QT molecular autopsy study of postmortem negative sudden death in 1 to 40 year olds

Effect of mutations in the PCSK9 gene on the cell surface LDL receptors

The risk of various types of cardiovascular diseases in mutation positive familial hypercholesterolemia; a review

Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treated

PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment

Role of the C-terminal domain of PCSK9 in degradation of the LDL receptors

Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993–2020

Cascade screening for familial hypercholesterolemia should be organized at a national level

Mutations in the SORT1 gene are unlikely to cause autosomal dominant hypercholesterolemia

Molecular genetics in 4408 cardiomyopathy probands and 3008 relatives in Norway: 17 years of genetic testing in a national laboratory

Bone morphogenetic protein 1 cleaves the linker region between ligand-binding repeats 4 and 5 of the LDL receptor and makes the LDL receptor non-functional

Berberine decreases PCSK9 expression in HepG2 cells

Retention of Mutant Low Density Lipoprotein Receptor in Endoplasmic Reticulum (ER) Leads to ER Stress

Molecular genetics in 1991 arrhythmia probands and 2782 relatives in Norway: Results from 17 years of genetic testing in a national laboratory

Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia

Excess Aortic Pathology Risk in Patients with Genetically Verified Familial Hypercholesterolaemia: A Prospective Norwegian Registry Study

The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: Results from twenty years of a national screening program in Norway

Suchergebnisse filtern